Adverse event reporting of the IGF-1R monoclonal antibody teprotumumab: a real-world study based on the US food and drug administration adverse event reporting system
Article in Frontiers in Pharmacology (August 2024)
The most recent citing publication is shown below. View this citation on Dimensions.
Article in Frontiers in Pharmacology (August 2024)